ConductScience.org, home

Paper19085068

Synergistic effects of miconazole and polymyxin B on microbial pathogens.

Pietschmann S and 3 others. Vet Res Commun, 2009. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Synergistic effects of miconazole and polymyxin B on microbial pathogens. Papers, record 19085068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19085068

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic effects of miconazole and polymyxin B on microbial pathogens.
PubMed
Journal
Vet Res Commun
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2024-05-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pietschmann SSilvia
2Hoffmann KKatrin
3Voget MMichael
4Pison UUlrich

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Antifungal AgentsMajor topic
BacteriaMajor topic
MalasseziaMajor topic
MiconazoleMajor topic
Polymyxin BMajor topic
Culture Media
Drug Combinations
Drug Synergism
Escherichia coli
Flow Cytometry
Microbial Sensitivity Tests
Microscopy, Fluorescence
Pseudomonas aeruginosa
Staphylococcus intermedius
Urea

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11406489Agents that increase the permeability of the outer membrane.Microbiol Rev1992https://conductscience.org/library/papers/1406489PubMed
216954293A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.J Clin Microbiol2006https://conductscience.org/library/papers/16954293PubMed
38667037In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.J Chemother1995https://conductscience.org/library/papers/8667037PubMed
44303542Electron microscopic studies on mode of action of polymyxin.J Bacteriol1969https://conductscience.org/library/papers/4303542PubMed
512234832Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12234832PubMed
65596142Synergy of antibacterial substances by apparently known mechanisms.Antimicrob Agents Chemother (Bethesda)1967https://conductscience.org/library/papers/5596142PubMed
7167658Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/167658PubMed
89065882New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa.J Small Anim Pract1997https://conductscience.org/library/papers/9065882PubMed
10101130Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/101130PubMed
1116238809A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.Vet Dermatol2005https://conductscience.org/library/papers/16238809PubMed
122580220Molecular basis of bacterial outer membrane permeability.Microbiol Rev1985https://conductscience.org/library/papers/2580220PubMed
13202585Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.J Antibiot (Tokyo)1977https://conductscience.org/library/papers/202585PubMed
1512489709Identification and antimicrobial susceptibility of coagulase positive staphylococci isolated from healthy dogs and dogs suffering from otitis externa.J Vet Med B Infect Dis Vet Public Health2002https://conductscience.org/library/papers/12489709PubMed
166317296Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B.Chemotherapy1983https://conductscience.org/library/papers/6317296PubMed
1716086654Update on antimicrobial agents: new indications of older agents.Expert Opin Pharmacother2005https://conductscience.org/library/papers/16086654PubMed
1815825399Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825399PubMed
196093683Alterations in outer membrane permeability.Annu Rev Microbiol1984https://conductscience.org/library/papers/6093683PubMed
201888310A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs.Aust Vet J1991https://conductscience.org/library/papers/1888310PubMed
2112805255Synergy, antagonism, and what the chequerboard puts between them.J Antimicrob Chemother2003https://conductscience.org/library/papers/12805255PubMed
227115614Synergism of the antimicrobial agents miconazole and benzoylperoxide.Br J Dermatol1982https://conductscience.org/library/papers/7115614PubMed

See all 29 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
38724627Miconazole and phenothiazine hinder the quorum sensing regulated virulence in Pseudomonas aeruginosa.J Antibiot (Tokyo)2024https://conductscience.org/library/papers/38724627PubMed
36558754Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations.Pathogens2022https://conductscience.org/library/papers/36558754PubMed
35467374Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.Microbiol Spectr2022https://conductscience.org/library/papers/35467374PubMed
34769486Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles.Int J Mol Sci2021https://conductscience.org/library/papers/34769486PubMed
33821795Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.Elife2021https://conductscience.org/library/papers/33821795PubMed
32984281Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide.Front Bioeng Biotechnol2020https://conductscience.org/library/papers/32984281PubMed
29706941Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens.Front Microbiol2018https://conductscience.org/library/papers/29706941PubMed
29371554Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis.J Fungi (Basel)2017https://conductscience.org/library/papers/29371554PubMed
28248999Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.PLoS One2017https://conductscience.org/library/papers/28248999PubMed
26138434Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.Mycopathologia2015https://conductscience.org/library/papers/26138434PubMed
25050379Development and characterization of polyphenon 60 and caffeine microemulsion for enhanced antibacterial activity.Biomed Res Int2014https://conductscience.org/library/papers/25050379PubMed
24629000The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide.BMC Microbiol2014https://conductscience.org/library/papers/24629000PubMed
24069959The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.BMC Microbiol2013https://conductscience.org/library/papers/24069959PubMed
23721182The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.Vet Dermatol2013https://conductscience.org/library/papers/23721182PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19085068

GET https://conductscience.org/api/papers/v1/19085068/references?page=2